Amyotrophic Lateral Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Amyotrophic Lateral Sclerosis Pipeline Drugs Market Overview
The symptoms of amyotrophic lateral sclerosis include difficulty breathing, difficulty swallowing, head drop due to weakness of the neck muscles, muscle cramps, speech problems, such as a slow or abnormal speech pattern (slurring of words), voice changes, hoarseness, weight loss.
The Amyotrophic Lateral Sclerosis pipeline drugs market research report provides comprehensive information on the therapeutics under development for Amyotrophic Lateral Sclerosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Amyotrophic Lateral Sclerosis and features dormant and discontinued projects.
Amyotrophic Lateral Sclerosis Pipeline Drugs Market Segmentation by Targets
The key targets in the Amyotrophic Lateral Sclerosis pipeline drugs market are TAR DNA Binding Protein 43, Superoxide Dismutase [Cu-Zn], Free Radical, Guanine Nucleotide Exchange C9orf72, Macrophage Colony Stimulating Factor 1 Receptor, 1 Phosphatidylinositol 3 Phosphate 5 Kinase, Apoptosis Regulator BAX, Kelch Like ECH Associated Protein 1, Ataxin 2, BDNF/NT 3 Growth Factors Receptor, and others.
Amyotrophic Lateral Sclerosis Pipeline Drugs Market Analysis by Targets
For more target insights into the Amyotrophic Lateral Sclerosis pipeline Drugs market, download a free report sample
Amyotrophic Lateral Sclerosis Pipeline Products Market Segmentation by Mechanisms of Action
The key mechanisms of action in the Amyotrophic Lateral Sclerosis pipeline products market are TAR DNA Binding Protein 43 Inhibitor, Superoxide Dismutase [Cu-Zn] Inhibitor, Free Radical Scavenger, Guanine Nucleotide Exchange C9orf72 Inhibitor, 1 Phosphatidylinositol 3 Phosphate 5 Kinase Inhibitor, Apoptosis Regulator BAX Inhibitor, Kelch Like ECH Associated Protein 1 Inhibitor, BDNF/NT 3 Growth Factors Receptor Agonist, Glial Cell Line Derived Neurotrophic Factor Activator, Interleukin 10 Activator, and others.
Amyotrophic Lateral Sclerosis Pipeline Products Market Analysis by Mechanisms of Action
For more mechanisms of action insights into the Amyotrophic Lateral Sclerosis pipeline products market, download a free report sample
Amyotrophic Lateral Sclerosis Pipeline Drugs Market Segmentation by Routes of Administration
The key routes of administration in the Amyotrophic Lateral Sclerosis pipeline drugs market are oral, intravenous, intrathecal, subcutaneous, parenteral, intramuscular, sublingual, topical, inhalational, intraarticular, and others.
Amyotrophic Lateral Sclerosis Pipeline Drugs Market Analysis by Routes of Administration
For more routes of administration insights into the Amyotrophic Lateral Sclerosis pipeline Drugs market, download a free report sample
Amyotrophic Lateral Sclerosis Pipeline Products Market Segmentation by Molecule Types
The key molecule types in the Amyotrophic Lateral Sclerosis pipeline products market are small molecule, gene therapy, cell therapy, monoclonal antibody, antisense oligonucleotide, synthetic peptide, recombinant protein, biologic, protein, antisense RNAi oligonucleotide, fusion protein, and others.
Amyotrophic Lateral Sclerosis Pipeline Products Market Analysis by Molecule Types
For more molecule type insights into the Amyotrophic Lateral Sclerosis pipeline products market, download a free report sample
Competitive Landscape
Some of the leading players in the Amyotrophic Lateral Sclerosis pipeline drugs market are Biogen Inc, 1st Bio Therapeutics Inc, AcuraStem Inc, Denali Therapeutics Inc, Mitsubishi Tanabe Pharma Corp, Orpheris Inc, ProMIS Neurosciences Inc, PurMinds NeuroPharma Inc, QurAlis Corporation, and Treeway BV.
Amyotrophic Lateral Sclerosis Pipeline Drugs Market Analysis by Players
To know more about the leading players in the Amyotrophic Lateral Sclerosis pipeline drugs market, download a free report sample
Amyotrophic Lateral Sclerosis Pipeline Products Market Report Overview
Key Targets | TAR DNA Binding Protein 43, Superoxide Dismutase [Cu-Zn], Free Radical, Guanine Nucleotide Exchange C9orf72, Macrophage Colony Stimulating Factor 1 Receptor, 1 Phosphatidylinositol 3 Phosphate 5 Kinase, Apoptosis Regulator BAX, Kelch Like ECH Associated Protein 1, Ataxin 2, BDNF/NT 3 Growth Factors Receptor, and Others |
Key Mechanisms of Action | TAR DNA Binding Protein 43 Inhibitor, Superoxide Dismutase [Cu-Zn] Inhibitor, Free Radical Scavenger, Guanine Nucleotide Exchange C9orf72 Inhibitor, 1 Phosphatidylinositol 3 Phosphate 5 Kinase Inhibitor, Apoptosis Regulator BAX Inhibitor, Kelch Like ECH Associated Protein 1 Inhibitor, BDNF/NT 3 Growth Factors Receptor Agonist, Glial Cell Line Derived Neurotrophic Factor Activator, Interleukin 10 Activator, and Others |
Key Routes of Administration | Oral, Intravenous, Intrathecal, Subcutaneous, Parenteral, Intramuscular, Sublingual, Topical, Inhalational, Intraarticular, and Others |
Key Molecule Type | Small Molecule, Gene Therapy, Cell Therapy, Monoclonal Antibody, Antisense Oligonucleotide, Synthetic Peptide, Recombinant Protein, Biologic, Protein, Antisense RNAi Oligonucleotide, Fusion Protein, and Others |
Leading Players | Biogen Inc, 1st Bio Therapeutics Inc, AcuraStem Inc, Denali Therapeutics Inc, Mitsubishi Tanabe Pharma Corp, Orpheris Inc, ProMIS Neurosciences Inc, PurMinds NeuroPharma Inc, QurAlis Corporation, Treeway BV, and Others |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Amyotrophic Lateral Sclerosis (Central Nervous System).
- The pipeline guide reviews pipeline therapeutics for Amyotrophic Lateral Sclerosis (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Amyotrophic Lateral Sclerosis (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Amyotrophic Lateral Sclerosis (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Amyotrophic Lateral Sclerosis (Central Nervous System)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolios and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Amyotrophic Lateral Sclerosis (Central Nervous System).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Amyotrophic Lateral Sclerosis (Central Nervous System) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
2N Pharma ApS
4B Technologies (Suzhou) Co Ltd
4P-Pharma SAS
AB Science SA
Abbisko Cayman Limited
Above and Beyond Concierge Therapeutics LLC
AC Immune SA
Aclipse One Inc
Aclipse Therapeutics LLC
Actimed Therapeutics Ltd
AcuraStem Inc
Adare Pharma Solutions
Aeterna Zentaris Inc
AgoneX Biopharmaceuticals Inc
AI Therapeutics Inc
AL-S Pharma AG
Alector Inc
Alexion Pharmaceuticals Inc
Allife Medical Science and Technology Co Ltd
Alnylam Pharmaceuticals Inc
AlphaCognition Inc
Alsonex Pty Ltd
Amarna Therapeutics BV
Amicogen Inc
Amplo Biotechnology Inc
Amylyx Pharmaceuticals Inc
Anima Biotech Inc
Ankar Pharma SL
ANLBio Co Ltd
Annexon Inc
Apellis Pharmaceuticals Inc
Apic Bio Inc
Apogenix AG
Applied Genetic Technologies Corp
Aquilus Pharmaceuticals Inc
Aquinnah Pharmaceuticals Inc
AriBio
ArmaGen Inc
ArunA Bio Inc
Asahi Kasei Pharma Corp
Asdera LLC
Asha Therapeutics LLC
Ashvattha Therapeutics LLC
Astellas Pharma Inc
Astrogen Ltd
Athira Pharma Inc
Autotac Bio Inc
Avanir Pharmaceuticals Inc
AviadoBio Ltd
Avrion Therapeutics AG
BenevolentAI Ltd
BioArctic AB
Bioasis Technologies Inc
Biogen Inc
Biohaven Pharmaceutical Holding Company Ltd
Bioleaders Corp
Biolexis Therapeutics Inc
Biorchestra Co Ltd
Bisichem Co Ltd
Bloom Science Inc
BrainEver SAS
BrainStorm Cell Therapeutics Inc
Bruschettini Srl
Calico Life Sciences LLC
Capsida Biotherapeutics Inc
CavoGene LifeSciences
CellCure
Cellenkos Inc
Ceptur Therapeutics Inc
Cerion LLC
Chaperone Therapeutics Inc
Chemigen LLC
Chiesi Farmaceutici SpA
CholesteniX Ltd
Chronos Therapeutics Ltd
Clene Inc
Clevexel Pharma SA
Clinigen Ltd
Coave Therapeutics
Codiak BioSciences Inc
Cogentis Therapeutics Inc
Collaborative Medicinal Development LLC
Constant Therapeutics LLC
Corcept Therapeutics Inc
Corestem Inc
Coya Therapeutics Inc
Curatis AG
CuroNZ Ltd
Cytokinetics Inc
Daiichi Sankyo Co Ltd
Deargen Inc
Denali Therapeutics Inc
Dewpoint Therapeutics Inc
Disarm Therapeutics Inc
DR.Noah Biotech Inc
Eikonizo Therapeutics Inc
Eikonoklastes Therapeutics Inc
Eisai Co Ltd
Eledon Pharmaceuticals Inc
Eli Lilly and Co
Elixiron Immunotherapeutics Inc
Elysium Health Inc
EmendoBio Inc
Emerald Health Sciences Inc
ENCEFA
Enveda Biosciences Inc
Enzerna Biosciences LLC
Eolo Pharma
Everfront Biotech Inc
Exicure Inc
Expansion Therapeutics Inc
Expesicor Inc
Faze medicines
Foshan Rexie Biotechnology Co Ltd
Gene Therapy Research Institution Co Ltd
Generoath Co Ltd
Genervon Biopharmaceuticals LLC
Genetic Intelligence Inc
GeNeuro SA
Genuv Inc
Glialogix Inc
GlyTag LLC
GNT Pharma Co Ltd
Grifols SA
Grupo Ferrer Internacional SA
Guangzhou Magpie Pharmaceutical Co Ltd
Helixmith Co Ltd
Hemostemix Inc
Herantis Pharma Plc
Hope Biosciences LLC
Hopstem Biotechnology LLC
Iltoo Pharma
Immunity Pharma Ltd
ImmunoBrain Checkpoint Inc
ImmunoForge Co Ltd
Implicit Bioscience Ltd
ImStar Therapeutics Inc
InFlectis BioScience SAS
Inmune Bio Inc
InnoMedica Holding AG
InnoPharmaScreen Inc
Io Therapeutics Inc
Ionis Pharmaceuticals Inc
Iron Horse Therapeutics Inc
Jiangsu Ouwei Pharmaceutical Co Ltd
Junaxo Inc
Jupiter Neurosciences Inc
K Pharma Inc
K-Pax Pharmaceuticals Inc
Kadimastem Ltd
Keapstone Therapeutics Ltd
KeifeRx LLC
Klogene Therapeutics Inc
Knopp Biosciences LLC
Kringle Pharma Inc
Kyorin Pharmaceutical Co Ltd
Lascco SA
Lauren Sciences LLC
LifeSplice Pharma LLC
Locanabio Inc
Longboard Pharmaceuticals Inc
Maas Biolab
Maze Therapeutics Inc
MD Healthcare Inc
MedDay SA
MeiraGTx Holdings Plc
Merck & Co Inc
MetrioPharm AG
MetVital Inc
MimeTech Srl
Mitochon Pharmaceuticals Inc
Mitochondria In Motion Inc
Mitoconix Bio Ltd
MitoDys Therapeutics Ltd
Mitsubishi Tanabe Pharma Corp
NeuExcell Therapeutics Inc
Neugen Pharma Inc
Neuracle Genetics Inc
Neuracle Science Co Ltd
Neurevo GmbH
Neurimmune Holding AG
Neurodegeneration Therapeutics Inc
NeuroGenesis Ltd
Neuromagen Pharma Ltd
Neuropath Therapeutics Ltd
Neuroplast BV
Neuropore Therapies Inc
NeuroSense Therapeutics Ltd
Neurotune AG
Neuvivo Inc
Nevrox Ltd
New Biotic Inc
Newron Pharmaceuticals SpA
Nine Square Therapeutics Inc
Nobelpharma Co Ltd
Novartis AG
Novartis Gene Therapies
NovelMed Therapeutics Inc
NuNerve Pty Ltd
NysnoBio LLC
Oncocross Co Ltd
OptiKira LLC
Orchard Therapeutics Plc
Origami Therapeutics Inc
Orpheris Inc
Palisade Bio, Inc
Parnia Stem Cell Knowledge-Based Co
Pasithea Therapeutics Corp
Passage Bio Inc
Pfizer Inc
PharmaTher Holdings Ltd
PharmAust Ltd
PharmEnable Ltd
Pharnext SA
Plex Pharmaceuticals Inc
PRG S&Tech Inc
Priavoid GmbH
Prilenia Therapeutics Development Ltd
Projenx Inc
ProMIS Neurosciences Inc
Prosetta Biosciences Inc
Prothena Corp Plc
Prous Institute for Biomedical Research SA
PTC Therapeutics Inc
PurMinds NeuroPharma Inc
Q Therapeutics Inc
Q-State Biosciences Inc
QurAlis Corporation
Ra Pharmaceuticals Inc
Rapa Therapeutics LLC
RASRx LLC
Reata Pharmaceuticals Inc
ReceptoPharm Inc
Regulus Therapeutics Inc
reMYND NV
ReoStem LLC
ResQ Biotech
Retrotope Inc
Revalesio Corp
Sangamo Therapeutics Inc
SciNeuro Pharmaceuticals
Seelos Therapeutics, Inc.
Shanghai Pharmaceuticals Holding Co Ltd
Shanghai Zhimeng Biopharma Inc
Shinkei Therapeutics LLC
Sio Gene Therapies Inc
SOLA Biosciences LLC
Spedding Research Solutions SAS
Spinogenix Inc
Stealth BioTherapeutics Corp
Suzhou Auzone Biological Technology Co Ltd
Symbinas Pharmaceuticals Inc
Takara Bio Inc
Talon Pharmaceutical Services Inc
Tasly Biopharmaceuticals Co Ltd
Tempero Bio
Thera Neuropharma Inc
Theragen Etex Co Ltd
Theratome Bio Inc
TikoMed AB
Tranquis Therapeutics Inc
Transposon Therapeutics Inc
Treeway BV
Treventis Corp
Triplet Therapeutics Inc
Ultragenyx Pharmaceutical Inc
UniQure NV
Unity Biotechnology Inc
Vanqua Bio Inc
Vaxxinity Inc
VectorY Therapeutics Inc
Velvio GmbH
Verge Genomics
Viridian Therapeutics Inc
Voronoi Group
Voyager Therapeutics Inc
Wave Life Sciences Ltd
Wren Therapeutics Ltd
Xalud Therapeutics Inc
XellSmart Biomedical (Shanghai) Co Ltd
Xonovo Inc
Yantai YenePharma Co Ltd
Yumanity Therapeutics Inc
Zhittya Genesis Medicine Inc
ZZ Biotech LLC
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the Amyotrophic Lateral Sclerosis pipeline products market?
The key targets in the Amyotrophic Lateral Sclerosis pipeline products market are TAR DNA Binding Protein 43, Superoxide Dismutase [Cu-Zn], Free Radical, Guanine Nucleotide Exchange C9orf72, Macrophage Colony Stimulating Factor 1 Receptor, 1 Phosphatidylinositol 3 Phosphate 5 Kinase, Apoptosis Regulator BAX, Kelch Like ECH Associated Protein 1, Ataxin 2, BDNF/NT 3 Growth Factors Receptor, and others.
-
What are the key mechanisms of action in the Amyotrophic Lateral Sclerosis pipeline products market?
The key mechanisms of action in the Amyotrophic Lateral Sclerosis pipeline products market are TAR DNA Binding Protein 43 Inhibitor, Superoxide Dismutase [Cu-Zn] Inhibitor, Free Radical Scavenger, Guanine Nucleotide Exchange C9orf72 Inhibitor, 1 Phosphatidylinositol 3 Phosphate 5 Kinase Inhibitor, Apoptosis Regulator BAX Inhibitor, Kelch Like ECH Associated Protein 1 Inhibitor, BDNF/NT 3 Growth Factors Receptor Agonist, Glial Cell Line Derived Neurotrophic Factor Activator, Interleukin 10 Activator, and others.
-
What are the key routes of administration in the Amyotrophic Lateral Sclerosis pipeline products market?
The key routes of administration in the Amyotrophic Lateral Sclerosis pipeline products market are oral, intravenous, intrathecal, subcutaneous, parenteral, intramuscular, sublingual, topical, inhalational, intraarticular, and others.
-
What are the key molecule types in the Amyotrophic Lateral Sclerosis pipeline products market?
The key molecule types in the Amyotrophic Lateral Sclerosis pipeline products market are small molecule, gene therapy, cell therapy, monoclonal antibody, antisense oligonucleotide, synthetic peptide, recombinant protein, biologic, protein, antisense RNAi oligonucleotide, fusion protein, and others.
-
Who are the leading players in the Amyotrophic Lateral Sclerosis pipeline products market?
Some of the leading players in the Amyotrophic Lateral Sclerosis pipeline products market are Biogen Inc, 1st Bio Therapeutics Inc, AcuraStem Inc, Denali Therapeutics Inc, Mitsubishi Tanabe Pharma Corp, Orpheris Inc, ProMIS Neurosciences Inc, PurMinds NeuroPharma Inc, QurAlis Corporation, and Treeway BV.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.